Endothelial dysfunction, nitric monooxide, and coronary heart disease

Endothelial dysfunction, nitric monooxide, and coronary heart disease

Bibliographic Details
Main Author:	N A Mazur
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2003-03-01
Series:	Терапевтический архив
Subjects:	review endothelial dysfunction nitric oxide coronary heart disease
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/29385

Similar Items

Pathophysiological importance of nitric oxide in coronary heart disease
by: Đorđević Vidosava B., et al.
Published: (2012-01-01)

The Role of Endothelial Microparticle in Coronary Heart Disease as The Complications of Diabetes Mellitus
by: Eka Fithra Elfi, et al.
Published: (2019-05-01)

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)

THE INFLUENCE OF CORONARY BYPASS ON ENDOTHELIAL AND ERECTILE DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: S. A. Pomeshkina, et al.
Published: (2015-01-01)

Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
by: M. V. Kazak, et al.
Published: (2011-10-01)

Possibilities for correcting endothelial dysfunction in patients with arterial hypertension and coronary heart disease
by: E. V. Filippov
Published: (2019-04-01)

Nitric oxide role and endothelial dysfunction development in diabetes mellitus
by: S. G. Dzugkoev, et al.
Published: (1970-01-01)

The Role of Nitric Oxide Metabolites in the Formation of Endothelial Dysfunction in Children with Persistent Bronchial Asthma
by: Yu.V. Odinets, et al.
Published: (2016-09-01)

Changes in Indicators of Oxidative Stress, Inflammation and Endothelial Dysfunction in Patients with Coronary Heart Disease during Lipid-Lowering Therapy
by: Julia A. Kotova, et al.
Published: (2019-09-01)

The features of risk factors, systemic inflammation, and endothelial dysfunction in patients with asthma concurrent with coronary heart disease
by: O V Belan, et al.
Published: (2014-03-01)

Relationship Between Indices of Oxidative Stress, Endothelial Dysfunction and Chaperone Activity and the Severity of Coronary Atherosclerosis
by: Julia A. Kotova, et al.
Published: (2018-09-01)

Diagnostic assessment of endothelial function in metabolic syndrome and coronary heart disease
by: V. A. Nevzorova, et al.
Published: (2011-04-01)

The clinical significance of endocardial endothelial dysfunction
by: Sonja Smiljic
Published: (2017-09-01)

Grounds for development of endothelial dysfunction in rheumatoid arthritis
by: A P Rebrov, et al.
Published: (2004-05-01)

Assessment of biomarkers of endothelial dysfunction in patients with angiographically proven coronary artery disease
by: Sanjay G Guddetwar, et al.
Published: (2020-01-01)

Tetrahydrobiopterin and Endothelial Dysfunction in Cardiovascular Diseases
by: Shinozaki Kazuya, et al.
Published: (2006-02-01)

Potential Role of eNOS Genetic Variants in Ischemic Heart Disease Susceptibility and Clinical Presentation
by: Paolo Severino, et al.
Published: (2021-09-01)

Endothelial function as a marker of pre-clinical atherosclerosis: assessment techniques and clinical implications
by: Donatella Ruggiero, et al.
Published: (2015-11-01)

Endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with coronary heart disease
by: N A Karoli, et al.
Published: (2019-03-01)

ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS
by: M. M. Petina, et al.
Published: (2011-04-01)

The Content of Vasodilation Factors in Blood Serum at Different Levels of Systolic- Diastolic Dysfunction of Left Ventricular with Stable Stenocardia Complicated by Heart Failure
by: Denesyuk V., et al.
Published: (2017-03-01)

Circulating Progenitor Cell Therapeutic Potential Impaired by Endothelial Dysfunction and Rescued by a Collagen Matrix
by: Marier, Jenelle
Published: (2012)

Circulating Progenitor Cell Therapeutic Potential Impaired by Endothelial Dysfunction and Rescued by a Collagen Matrix
by: Marier, Jenelle
Published: (2012)

Circulating Progenitor Cell Therapeutic Potential Impaired by Endothelial Dysfunction and Rescued by a Collagen Matrix
by: Marier, Jenelle
Published: (2012)

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells
by: Xiaomei Ren, et al.
Published: (2017-04-01)

Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease
by: A Kh Akhmineeva
Published: (2014-03-01)

PREVALENCE AND DYNAMICS OF ENDOTHELIAL DYSFUNCTION, CAROTID AND CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC RHEUMATIC HEART DISEASE
by: V. S. Petrov
Published: (2018-11-01)

Endothelial nitric oxide synthase Asp298Glu (894G/T) gene polymorphism as a possible risk factor for the coronary slow flow phenomenon among Iranians
by: Bakhshandeh, H., et al.
Published: (2022)

Vascular Kinin B1 and B2 Receptors Determine Endothelial Dysfunction through Neuronal Nitric Oxide Synthase
by: Luciano Dos Santos A. Capettini, et al.
Published: (2017-04-01)

Markers of Endothelial Damage, Inflammation, Oxidative and Cellular Stress in Patients with Coronary Artery Disease and Type 2 Diabetes
by: Julia A. Kotova, et al.
Published: (2020-06-01)

Endothelial Dysfunction in Obese Children
by: Namrata Chhabra, et al.
Published: (2015-04-01)

PHARMACOTHERAPEUTIC STRATEGIES FOR ENDOTHELIAL DYSFUNCTION CORRECTION WITH USE OF STATINES IN SYNDROME OF SYSTEMIC INFLAMMATORY RESPONSE
by: Tatiana Denisyuk
Published: (2017-12-01)

Pharmacological correction of plasma redox potential and endothelial dysfunction in ischemic heart failure
by: O. P. Donetskaya, et al.
Published: (2012-02-01)

Association between Polymorphism of Endothelial Nitric Oxide Synthase Gene (Glu298Asp) and Chronic Heart Failure in Patients with Ischemic Heart Disease and Obesity
by: O.I. Kadykova, et al.
Published: (2016-03-01)

TYPE 2 DIABETES MELLITUS AND CORONARY HEART DISEASE
by: T. P. Bardymova, et al.
Published: (2017-02-01)

NO-synthase activity in patients with coronary heart disease associated with hypertension of different age groups
by: Besedina Anna
Published: (2016-01-01)

Endothelial dysfunction in high fructose containing diet fed rats: Increased nitric oxide and decreased endothelin-1 levels in liver tissue
by: Zeki Arı, et al.
Published: (2010-09-01)

Vasoactive mediators of endothelial dysfunction in children and teenagers with hypertension
by: D. I. Sadykova, et al.
Published: (2016-03-01)

Clinical effectiveness of pioglitazone in the combination treatment of patients with asthma concurrent with coronary heart disease
by: O V Byelan, et al.
Published: (2015-09-01)